MDPI and ACS Style
Mahroum, N.; Watad, A.; Bridgewood, C.; Mansour, M.; Nasr, A.; Hussein, A.; Khamisy-Farah, R.; Farah, R.; Gendelman, O.; Lidar, M.;
et al. Systematic Review and Meta-Analysis of Tocilizumab Therapy versus Standard of Care in over 15,000 COVID-19 Pneumonia Patients during the First Eight Months of the Pandemic. Int. J. Environ. Res. Public Health 2021, 18, 9149.
https://doi.org/10.3390/ijerph18179149
AMA Style
Mahroum N, Watad A, Bridgewood C, Mansour M, Nasr A, Hussein A, Khamisy-Farah R, Farah R, Gendelman O, Lidar M,
et al. Systematic Review and Meta-Analysis of Tocilizumab Therapy versus Standard of Care in over 15,000 COVID-19 Pneumonia Patients during the First Eight Months of the Pandemic. International Journal of Environmental Research and Public Health. 2021; 18(17):9149.
https://doi.org/10.3390/ijerph18179149
Chicago/Turabian Style
Mahroum, Naim, Abdulla Watad, Charlie Bridgewood, Muhammad Mansour, Ahmad Nasr, Amr Hussein, Rola Khamisy-Farah, Raymond Farah, Omer Gendelman, Merav Lidar,
and et al. 2021. "Systematic Review and Meta-Analysis of Tocilizumab Therapy versus Standard of Care in over 15,000 COVID-19 Pneumonia Patients during the First Eight Months of the Pandemic" International Journal of Environmental Research and Public Health 18, no. 17: 9149.
https://doi.org/10.3390/ijerph18179149